img

Global and United States Molecular Residual Disease Detection Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global and United States Molecular Residual Disease Detection Market Report & Forecast 2024-2034

Molecular residual lesions often refer to minimal residual lesions, which refer to a small number of cancer cells that remain in the body after cancer treatment (cancer cells that do not respond to treatment or are drug-resistant).
Market Analysis and InsightsGlobal and United States Molecular Residual Disease Detection Market
This report focuses on global and United States Molecular Residual Disease Detection market, also covers the segmentation data of other regions in regional level and county level.
The global Molecular Residual Disease Detection revenue was US$ 4680 million in 2022 and is forecast to a readjusted size of US$ 12900 million by 2033 with a CAGR of 15.6% during the review period (2023-2033).
In United States the Molecular Residual Disease Detection revenue is expected to grow from US$ million in 2022 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Molecular Residual Disease Detection include Adaptive, Guardant Health, Invitae, Cergentis B.V, LexentBio, Natera, BGI, Zhiben Medical and Burning Rock Medicine, etc. The global five biggest players hold a share of % in 2022.
Global Molecular Residual Disease Detection Scope and Market Size
Molecular Residual Disease Detection market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Molecular Residual Disease Detection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the Molecular Residual Disease Detection market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.



By Company


Adaptive
Guardant Health
Invitae
Cergentis B.V
LexentBio
Natera
BGI
Zhiben Medical
Burning Rock Medicine
Huidu Medical
Zhenhe Technology
ExactSciences
Segment by Type
Tumor-informed Assays
Tumor-agnostic Assays

Segment by Application


Prognosis
Adjuvant Treatment Decision-Making
Surveillance for Postoperative Recurrence
Other
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Molecular Residual Disease Detection definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Molecular Residual Disease Detection companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Molecular Residual Disease Detection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Molecular Residual Disease Detection revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Molecular Residual Disease Detection Product Introduction
1.2 Global Molecular Residual Disease Detection Outlook 2018 VS 2022 VS 2033
1.2.1 Global Molecular Residual Disease Detection Market Size for the Year 2018-2033
1.2.2 United States Molecular Residual Disease Detection Market Size for the Year 2018-2033
1.3 Molecular Residual Disease Detection Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.3.1 The Market Share of United States Molecular Residual Disease Detection in Global, 2018 VS 2022 VS 2033
1.3.2 The Growth Rate of Molecular Residual Disease Detection Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.4 Molecular Residual Disease Detection Market Dynamics
1.4.1 Molecular Residual Disease Detection Industry Trends
1.4.2 Molecular Residual Disease Detection Market Drivers
1.4.3 Molecular Residual Disease Detection Market Challenges
1.4.4 Molecular Residual Disease Detection Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Molecular Residual Disease Detection by Type
2.1 Molecular Residual Disease Detection Market Segment by Type
2.1.1 Tumor-informed Assays
2.1.2 Tumor-agnostic Assays
2.2 Global Molecular Residual Disease Detection Market Size by Type (2018, 2022 & 2033)
2.3 Global Molecular Residual Disease Detection Market Size by Type (2018-2033)
2.4 United States Molecular Residual Disease Detection Market Size by Type (2018, 2022 & 2033)
2.5 United States Molecular Residual Disease Detection Market Size by Type (2018-2033)
3 Molecular Residual Disease Detection by Application
3.1 Molecular Residual Disease Detection Market Segment by Application
3.1.1 Prognosis
3.1.2 Adjuvant Treatment Decision-Making
3.1.3 Surveillance for Postoperative Recurrence
3.1.4 Other
3.2 Global Molecular Residual Disease Detection Market Size by Application (2018, 2022 & 2033)
3.3 Global Molecular Residual Disease Detection Market Size by Application (2018-2033)
3.4 United States Molecular Residual Disease Detection Market Size by Application (2018, 2022 & 2033)
3.5 United States Molecular Residual Disease Detection Market Size by Application (2018-2033)
4 Global Molecular Residual Disease Detection Competitor Landscape by Company
4.1 Global Molecular Residual Disease Detection Market Size by Company
4.1.1 Global Key Companies of Molecular Residual Disease Detection, Ranked by Revenue (2022)
4.1.2 Global Molecular Residual Disease Detection Revenue by Player (2018-2023)
4.2 Global Molecular Residual Disease Detection Concentration Ratio (CR)
4.2.1 Molecular Residual Disease Detection Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Molecular Residual Disease Detection in 2022
4.2.3 Global Molecular Residual Disease Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Molecular Residual Disease Detection Head office and Area Served
4.4 Global Key Players of Molecular Residual Disease Detection, Product and Application
4.5 Global Key Players of Molecular Residual Disease Detection, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Molecular Residual Disease Detection Market Size by Company
4.7.1 Key Players of Molecular Residual Disease Detection in United States, Ranked by Revenue (2022)
4.7.2 United States Molecular Residual Disease Detection Revenue by Players (2021, 2022 & 2023)
5 Global Molecular Residual Disease Detection Market Size by Region
5.1 Global Molecular Residual Disease Detection Market Size by Region: 2018 VS 2022 VS 2033
5.2 Global Molecular Residual Disease Detection Market Size by Region (2018-2033)
5.2.1 Global Molecular Residual Disease Detection Market Size by Region: 2018-2023
5.2.2 Global Molecular Residual Disease Detection Market Size by Region (2024-2033)
6 Americas
6.1 Americas Molecular Residual Disease Detection Market Size YoY Growth 2018-2033
6.2 Americas Molecular Residual Disease Detection Market Size by Type
6.2.1 Americas Molecular Residual Disease Detection Market Size by Type (2018-2023)
6.2.2 Americas Molecular Residual Disease Detection Market Size by Type (2024-2033)
6.2.3 Americas Molecular Residual Disease Detection Market Share by Type (2018-2033)
6.3 Americas Molecular Residual Disease Detection Market Size by Application
6.3.1 Americas Molecular Residual Disease Detection Market Size by Application (2018-2023)
6.3.2 Americas Molecular Residual Disease Detection Market Size by Application (2024-2033)
6.3.3 Americas Molecular Residual Disease Detection Market Share by Application (2018-2033)
6.4 Americas Molecular Residual Disease Detection Market Facts & Figures by Country (2018, 2022 & 2033)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Molecular Residual Disease Detection Market Size YoY Growth 2018-2033
7.2 EMEA Molecular Residual Disease Detection Market Size by Type
7.2.1 EMEA Molecular Residual Disease Detection Market Size by Type (2018-2023)
7.2.2 EMEA Molecular Residual Disease Detection Market Size by Type (2024-2033)
7.2.3 EMEA Molecular Residual Disease Detection Market Share by Type (2018-2033)
7.3 EMEA Molecular Residual Disease Detection Market Size by Application
7.3.1 EMEA Molecular Residual Disease Detection Market Size by Application (2018-2023)
7.3.2 EMEA Molecular Residual Disease Detection Market Size by Application (2024-2033)
7.3.3 EMEA Molecular Residual Disease Detection Market Share by Application (2018-2033)
7.4 EMEA Molecular Residual Disease Detection Market Facts & Figures by Country (2018, 2022 & 2033)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Molecular Residual Disease Detection Market Size YoY Growth 2018-2033
8.2 China Molecular Residual Disease Detection Market Size by Type
8.2.1 China Molecular Residual Disease Detection Market Size by Type (2018-2023)
8.2.2 China Molecular Residual Disease Detection Market Size by Type (2024-2033)
8.2.3 China Molecular Residual Disease Detection Market Share by Type (2018-2033)
8.3 China Molecular Residual Disease Detection Market Size by Application
8.3.1 China Molecular Residual Disease Detection Market Size by Application (2018-2023)
8.3.2 China Molecular Residual Disease Detection Market Size by Application (2024-2033)
8.3.3 China Molecular Residual Disease Detection Market Share by Application (2018-2033)
9 APAC (excluding China)
9.1 APAC Molecular Residual Disease Detection Market Size YoY Growth 2018-2033
9.2 APAC Molecular Residual Disease Detection Market Size by Type
9.2.1 APAC Molecular Residual Disease Detection Market Size by Type (2018-2023)
9.2.2 APAC Molecular Residual Disease Detection Market Size by Type (2024-2033)
9.2.3 APAC Molecular Residual Disease Detection Market Share by Type (2018-2033)
9.3 APAC Molecular Residual Disease Detection Market Size by Application
9.3.1 APAC Molecular Residual Disease Detection Market Size by Application (2018-2023)
9.3.2 APAC Molecular Residual Disease Detection Market Size by Application (2024-2033)
9.3.3 APAC Molecular Residual Disease Detection Market Share by Application (2018-2033)
9.4 APAC Molecular Residual Disease Detection Market Facts & Figures by Country (2018, 2022 & 2033)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Adaptive
10.1.1 Adaptive Company Details
10.1.2 Adaptive Business Overview
10.1.3 Adaptive Molecular Residual Disease Detection Introduction
10.1.4 Adaptive Revenue in Molecular Residual Disease Detection Business (2018-2023)
10.1.5 Adaptive Recent Development
10.2 Guardant Health
10.2.1 Guardant Health Company Details
10.2.2 Guardant Health Business Overview
10.2.3 Guardant Health Molecular Residual Disease Detection Introduction
10.2.4 Guardant Health Revenue in Molecular Residual Disease Detection Business (2018-2023)
10.2.5 Guardant Health Recent Development
10.3 Invitae
10.3.1 Invitae Company Details
10.3.2 Invitae Business Overview
10.3.3 Invitae Molecular Residual Disease Detection Introduction
10.3.4 Invitae Revenue in Molecular Residual Disease Detection Business (2018-2023)
10.3.5 Invitae Recent Development
10.4 Cergentis B.V
10.4.1 Cergentis B.V Company Details
10.4.2 Cergentis B.V Business Overview
10.4.3 Cergentis B.V Molecular Residual Disease Detection Introduction
10.4.4 Cergentis B.V Revenue in Molecular Residual Disease Detection Business (2018-2023)
10.4.5 Cergentis B.V Recent Development
10.5 LexentBio
10.5.1 LexentBio Company Details
10.5.2 LexentBio Business Overview
10.5.3 LexentBio Molecular Residual Disease Detection Introduction
10.5.4 LexentBio Revenue in Molecular Residual Disease Detection Business (2018-2023)
10.5.5 LexentBio Recent Development
10.6 Natera
10.6.1 Natera Company Details
10.6.2 Natera Business Overview
10.6.3 Natera Molecular Residual Disease Detection Introduction
10.6.4 Natera Revenue in Molecular Residual Disease Detection Business (2018-2023)
10.6.5 Natera Recent Development
10.7 BGI
10.7.1 BGI Company Details
10.7.2 BGI Business Overview
10.7.3 BGI Molecular Residual Disease Detection Introduction
10.7.4 BGI Revenue in Molecular Residual Disease Detection Business (2018-2023)
10.7.5 BGI Recent Development
10.8 Zhiben Medical
10.8.1 Zhiben Medical Company Details
10.8.2 Zhiben Medical Business Overview
10.8.3 Zhiben Medical Molecular Residual Disease Detection Introduction
10.8.4 Zhiben Medical Revenue in Molecular Residual Disease Detection Business (2018-2023)
10.8.5 Zhiben Medical Recent Development
10.9 Burning Rock Medicine
10.9.1 Burning Rock Medicine Company Details
10.9.2 Burning Rock Medicine Business Overview
10.9.3 Burning Rock Medicine Molecular Residual Disease Detection Introduction
10.9.4 Burning Rock Medicine Revenue in Molecular Residual Disease Detection Business (2018-2023)
10.9.5 Burning Rock Medicine Recent Development
10.10 Huidu Medical
10.10.1 Huidu Medical Company Details
10.10.2 Huidu Medical Business Overview
10.10.3 Huidu Medical Molecular Residual Disease Detection Introduction
10.10.4 Huidu Medical Revenue in Molecular Residual Disease Detection Business (2018-2023)
10.10.5 Huidu Medical Recent Development
10.11 Zhenhe Technology
10.11.1 Zhenhe Technology Company Details
10.11.2 Zhenhe Technology Business Overview
10.11.3 Zhenhe Technology Molecular Residual Disease Detection Introduction
10.11.4 Zhenhe Technology Revenue in Molecular Residual Disease Detection Business (2018-2023)
10.11.5 Zhenhe Technology Recent Development
10.12 ExactSciences
10.12.1 ExactSciences Company Details
10.12.2 ExactSciences Business Overview
10.12.3 ExactSciences Molecular Residual Disease Detection Introduction
10.12.4 ExactSciences Revenue in Molecular Residual Disease Detection Business (2018-2023)
10.12.5 ExactSciences Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Molecular Residual Disease Detection Market Size United States VS Global, CAGR (2018 VS 2022 VS 2033)
Table 2. Molecular Residual Disease Detection Market Trends
Table 3. Molecular Residual Disease Detection Market Drivers
Table 4. Molecular Residual Disease Detection Market Challenges
Table 5. Molecular Residual Disease Detection Market Restraints
Table 6. Global Molecular Residual Disease Detection Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 7. United States Molecular Residual Disease Detection Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 8. Global Molecular Residual Disease Detection Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 9. United States Molecular Residual Disease Detection Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 10. Global Key Companies of Molecular Residual Disease Detection, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Molecular Residual Disease Detection Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Molecular Residual Disease Detection Revenue Share by Player, 2018-2023
Table 13. Global Molecular Residual Disease Detection Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Molecular Residual Disease Detection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Residual Disease Detection as of 2022)
Table 15. Global Key Players of Molecular Residual Disease Detection, Headquarters and Area Served
Table 16. Global Key Players of Molecular Residual Disease Detection, Product and Application
Table 17. Global Key Players of Molecular Residual Disease Detection, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Molecular Residual Disease Detection in United States, Ranked by Revenue (2022) & (US$ Million)
Table 20. United States Molecular Residual Disease Detection Revenue by Players, (US$ Million), 2021, 2022 & 2023
Table 21. United States Molecular Residual Disease Detection Revenue Share by Players, 2021, 2022 & 2023
Table 22. Global Molecular Residual Disease Detection Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 23. Global Molecular Residual Disease Detection Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Molecular Residual Disease Detection Market Size Forecast by Region (2024-2033) & (US$ Million)
Table 25. Americas Molecular Residual Disease Detection Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Molecular Residual Disease Detection Market Size by Type (2024-2033) & (US$ Million)
Table 27. Americas Molecular Residual Disease Detection Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Molecular Residual Disease Detection Market Size by Application (2024-2033) & (US$ Million)
Table 29. Americas Molecular Residual Disease Detection Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 30. Americas Molecular Residual Disease Detection Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Molecular Residual Disease Detection Market Size by Country (2024-2033) & (US$ Million)
Table 32. EMEA Molecular Residual Disease Detection Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Molecular Residual Disease Detection Market Size by Type (2024-2033) & (US$ Million)
Table 34. EMEA Molecular Residual Disease Detection Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Molecular Residual Disease Detection Market Size by Application (2024-2033) & (US$ Million)
Table 36. EMEA Molecular Residual Disease Detection Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. EMEA Molecular Residual Disease Detection Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Molecular Residual Disease Detection Market Size by Country (2024-2033) & (US$ Million)
Table 39. China Molecular Residual Disease Detection Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Molecular Residual Disease Detection Market Size by Type (2024-2033) & (US$ Million)
Table 41. China Molecular Residual Disease Detection Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Molecular Residual Disease Detection Market Size by Application (2024-2033) & (US$ Million)
Table 43. China Molecular Residual Disease Detection Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. APAC Molecular Residual Disease Detection Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Molecular Residual Disease Detection Market Size by Type (2024-2033) & (US$ Million)
Table 46. APAC Molecular Residual Disease Detection Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Molecular Residual Disease Detection Market Size by Application (2024-2033) & (US$ Million)
Table 48. APAC Molecular Residual Disease Detection Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. APAC Molecular Residual Disease Detection Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Molecular Residual Disease Detection Market Size by Region (2024-2033) & (US$ Million)
Table 51. Adaptive Company Details
Table 52. Adaptive Business Overview
Table 53. Adaptive Molecular Residual Disease Detection Product
Table 54. Adaptive Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 55. Adaptive Recent Development
Table 56. Guardant Health Company Details
Table 57. Guardant Health Business Overview
Table 58. Guardant Health Molecular Residual Disease Detection Product
Table 59. Guardant Health Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 60. Guardant Health Recent Development
Table 61. Invitae Company Details
Table 62. Invitae Business Overview
Table 63. Invitae Molecular Residual Disease Detection Product
Table 64. Invitae Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 65. Invitae Recent Development
Table 66. Cergentis B.V Company Details
Table 67. Cergentis B.V Business Overview
Table 68. Cergentis B.V Molecular Residual Disease Detection Product
Table 69. Cergentis B.V Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 70. Cergentis B.V Recent Development
Table 71. LexentBio Company Details
Table 72. LexentBio Business Overview
Table 73. LexentBio Molecular Residual Disease Detection Product
Table 74. LexentBio Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 75. LexentBio Recent Development
Table 76. Natera Company Details
Table 77. Natera Business Overview
Table 78. Natera Molecular Residual Disease Detection Product
Table 79. Natera Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 80. Natera Recent Development
Table 81. BGI Company Details
Table 82. BGI Business Overview
Table 83. BGI Molecular Residual Disease Detection Product
Table 84. BGI Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 85. BGI Recent Development
Table 86. Zhiben Medical Company Details
Table 87. Zhiben Medical Business Overview
Table 88. Zhiben Medical Molecular Residual Disease Detection Product
Table 89. Zhiben Medical Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 90. Zhiben Medical Recent Development
Table 91. Burning Rock Medicine Company Details
Table 92. Burning Rock Medicine Business Overview
Table 93. Burning Rock Medicine Molecular Residual Disease Detection Product
Table 94. Burning Rock Medicine Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 95. Burning Rock Medicine Recent Development
Table 96. Huidu Medical Company Details
Table 97. Huidu Medical Business Overview
Table 98. Huidu Medical Molecular Residual Disease Detection Product
Table 99. Huidu Medical Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 100. Huidu Medical Recent Development
Table 101. Zhenhe Technology Company Details
Table 102. Zhenhe Technology Business Overview
Table 103. Zhenhe Technology Molecular Residual Disease Detection Product
Table 104. Zhenhe Technology Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 105. Zhenhe Technology Recent Development
Table 106. ExactSciences Company Details
Table 107. ExactSciences Business Overview
Table 108. ExactSciences Molecular Residual Disease Detection Product
Table 109. ExactSciences Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 110. ExactSciences Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Molecular Residual Disease Detection Product Picture
Figure 2. Global Molecular Residual Disease Detection Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Molecular Residual Disease Detection Market Size 2018-2033 (US$ Million)
Figure 4. United States Molecular Residual Disease Detection Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 5. United States Molecular Residual Disease Detection Market Size 2018-2033 (US$ Million)
Figure 6. United States Molecular Residual Disease Detection Market Share in Global 2018-2033
Figure 7. Molecular Residual Disease Detection Report Years Considered
Figure 8. Product Picture of Tumor-informed Assays
Figure 9. Product Picture of Tumor-agnostic Assays
Figure 10. Global Molecular Residual Disease Detection Market Share by Type in 2022 & 2033
Figure 11. Global Molecular Residual Disease Detection Market Size by Type (2018-2033) & (US$ Million)
Figure 12. Global Molecular Residual Disease Detection Market Share by Type (2018-2033)
Figure 13. United States Molecular Residual Disease Detection Market Share by Type in 2022 & 2033
Figure 14. United States Molecular Residual Disease Detection Market Size by Type (2018-2033) & (US$ Million)
Figure 15. United States Molecular Residual Disease Detection Market Share by Type (2018-2033)
Figure 16. Product Picture of Prognosis
Figure 17. Product Picture of Adjuvant Treatment Decision-Making
Figure 18. Product Picture of Surveillance for Postoperative Recurrence
Figure 19. Product Picture of Other
Figure 20. Global Molecular Residual Disease Detection Market Share by Application in 2022 & 2033
Figure 21. Global Molecular Residual Disease Detection Market Size by Application (2018-2033) & (US$ Million)
Figure 22. Global Molecular Residual Disease Detection Market Share by Application (2018-2033)
Figure 23. United States Molecular Residual Disease Detection Market Share by Application in 2022 & 2033
Figure 24. United States Molecular Residual Disease Detection Market Size by Application (2018-2033) & (US$ Million)
Figure 25. United States Molecular Residual Disease Detection Market Share by Application (2018-2033)
Figure 26. The Top 5 and 10 Largest Companies of Molecular Residual Disease Detection in the World: Market Share by Molecular Residual Disease Detection Revenue in 2022
Figure 27. Global Molecular Residual Disease Detection Market Size Market Share by Region: 2018 VS 2022 VS 2033
Figure 28. Global Molecular Residual Disease Detection Market Share by Region (2018-2033)
Figure 29. Americas Molecular Residual Disease Detection Market Size Growth Rate 2018-2033 (US$ Million)
Figure 30. Americas Molecular Residual Disease Detection Market Share by Type (2018-2033)
Figure 31. Americas Molecular Residual Disease Detection Market Share by Application (2018-2033)
Figure 32. United States Molecular Residual Disease Detection Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 33. Canada Molecular Residual Disease Detection Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 34. Mexico Molecular Residual Disease Detection Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 35. Brazil Molecular Residual Disease Detection Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 36. EMEA Molecular Residual Disease Detection Market Size Growth Rate 2018-2033 (US$ Million)
Figure 37. EMEA Molecular Residual Disease Detection Market Share by Type (2018-2033)
Figure 38. EMEA Molecular Residual Disease Detection Market Share by Application (2018-2033)
Figure 39. Europe Molecular Residual Disease Detection Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 40. Middle East Molecular Residual Disease Detection Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 41. Africa Molecular Residual Disease Detection Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 42. China Molecular Residual Disease Detection Market Size Growth Rate 2018-2033 (US$ Million)
Figure 43. China Molecular Residual Disease Detection Market Share by Type (2018-2033)
Figure 44. China Molecular Residual Disease Detection Market Share by Application (2018-2033)
Figure 45. APAC Molecular Residual Disease Detection Market Size Growth Rate 2018-2033 (US$ Million)
Figure 46. APAC Molecular Residual Disease Detection Market Share by Type (2018-2033)
Figure 47. APAC Molecular Residual Disease Detection Market Share by Application (2018-2033)
Figure 48. Japan Molecular Residual Disease Detection Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 49. South Korea Molecular Residual Disease Detection Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 50. China Taiwan Molecular Residual Disease Detection Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 51. Southeast Asia Molecular Residual Disease Detection Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 52. India Molecular Residual Disease Detection Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 53. Adaptive Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 54. Guardant Health Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 55. Invitae Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 56. Cergentis B.V Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 57. LexentBio Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 58. Natera Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 59. BGI Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 60. Zhiben Medical Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 61. Burning Rock Medicine Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 62. Huidu Medical Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 63. Zhenhe Technology Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 64. ExactSciences Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries